2023 Q4 Form 10-Q Financial Statement
#000155837023018696 Filed on November 13, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | -100.0% | |
Cost Of Revenue | $0.00 | $0.00 |
YoY Change | -100.0% | |
Gross Profit | $0.00 | $0.00 |
YoY Change | -100.0% | |
Gross Profit Margin | ||
Selling, General & Admin | $4.623M | $4.952M |
YoY Change | -20.72% | -48.14% |
% of Gross Profit | ||
Research & Development | $4.718M | $5.554M |
YoY Change | 41.98% | 3.02% |
% of Gross Profit | ||
Depreciation & Amortization | $73.00K | $80.00K |
YoY Change | -8.75% | -47.02% |
% of Gross Profit | ||
Operating Expenses | $9.619M | $8.762M |
YoY Change | -6.17% | -41.54% |
Operating Profit | -$9.619M | -$8.762M |
YoY Change | -6.17% | -39.86% |
Interest Expense | -$858.0K | $1.459M |
YoY Change | -29.84% | 0.83% |
% of Operating Profit | ||
Other Income/Expense, Net | $1.850M | $58.00K |
YoY Change | -235.14% | -99.87% |
Pretax Income | -$8.627M | -$8.700M |
YoY Change | -32.83% | -129.92% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$8.627M | -$8.704M |
YoY Change | -32.83% | -129.94% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | -$3.41 | |
Diluted Earnings Per Share | -$3.18 | -$3.41 |
COMMON SHARES | ||
Basic Shares Outstanding | 2.693M | 2.543M |
Diluted Shares Outstanding | 2.550M |
Balance Sheet
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $50.90M | $56.10M |
YoY Change | -27.8% | 7.08% |
Cash & Equivalents | $50.90M | $56.06M |
Short-Term Investments | ||
Other Short-Term Assets | $1.739M | $1.500M |
YoY Change | -88.6% | -95.33% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $117.0K | $100.0K |
Other Receivables | $119.0K | $200.0K |
Total Short-Term Assets | $52.87M | $57.90M |
YoY Change | -38.48% | -31.62% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $2.778M | $802.0K |
YoY Change | 594.5% | 55.13% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $301.0K | $300.0K |
YoY Change | -34.85% | -36.84% |
Total Long-Term Assets | $3.079M | $3.218M |
YoY Change | 250.68% | 213.65% |
TOTAL ASSETS | ||
Total Short-Term Assets | $52.87M | $57.90M |
Total Long-Term Assets | $3.079M | $3.218M |
Total Assets | $55.95M | $61.12M |
YoY Change | -35.56% | -28.68% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $919.0K | $787.0K |
YoY Change | -67.55% | -89.29% |
Accrued Expenses | $6.352M | $6.260M |
YoY Change | -28.71% | -75.32% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $0.00 | |
YoY Change | ||
Total Short-Term Liabilities | $8.346M | $10.30M |
YoY Change | -67.51% | -74.4% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $34.19M | $33.88M |
YoY Change | -9.88% | -20.55% |
Other Long-Term Liabilities | $5.909M | $5.700M |
YoY Change | 39.89% | 50.67% |
Total Long-Term Liabilities | $40.10M | $39.60M |
YoY Change | -4.89% | -14.71% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $8.346M | $10.30M |
Total Long-Term Liabilities | $40.10M | $39.60M |
Total Liabilities | $48.45M | $49.90M |
YoY Change | -28.6% | -42.43% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$629.4M | -$620.8M |
YoY Change | 7.19% | 8.08% |
Common Stock | $3.000K | $3.000K |
YoY Change | 50.0% | 200.0% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $7.504M | $11.22M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $55.95M | $61.12M |
YoY Change | -35.56% | -28.68% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$8.627M | -$8.704M |
YoY Change | -32.83% | -129.94% |
Depreciation, Depletion And Amortization | $73.00K | $80.00K |
YoY Change | -8.75% | -47.02% |
Cash From Operating Activities | -$7.697M | -$2.950M |
YoY Change | -43.96% | -81.17% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $10.00K | $280.0K |
YoY Change | -54.55% | -836.84% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $1.000K | $10.00M |
YoY Change | -98.63% | -84.6% |
Cash From Investing Activities | -$9.000K | $9.720M |
YoY Change | -117.65% | -85.03% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 2.536M | 40.00K |
YoY Change | -92.02% | -100.1% |
NET CHANGE | ||
Cash From Operating Activities | -7.697M | -2.950M |
Cash From Investing Activities | -9.000K | 9.720M |
Cash From Financing Activities | 2.536M | 40.00K |
Net Change In Cash | -5.170M | 6.810M |
YoY Change | -128.56% | -27.35% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$7.697M | -$2.950M |
Capital Expenditures | $10.00K | $280.0K |
Free Cash Flow | -$7.707M | -$3.230M |
YoY Change | -43.98% | -79.33% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001479419 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1706971 | |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2693116 | |
kala |
Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
|
0 | ||
CY2023Q3 | kala |
Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
|
0 | |
CY2022 | kala |
Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
|
0 | |
kala |
Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
|
0 | ||
CY2023Q3 | kala |
Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
|
0 | |
CY2022 | kala |
Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
|
0 | |
kala |
Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
|
0 | ||
CY2023Q3 | kala |
Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
|
0 | |
CY2022 | kala |
Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
|
0 | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | ||
CY2023Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
CY2022 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | ||
CY2023Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | |
CY2022 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | ||
CY2023Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
CY2022 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | ||
CY2023Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
CY2022 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
CY2022Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.02 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1 | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-38150 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
KALA BIO, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
27-0604595 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1167 Massachusetts Avenue | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Arlington | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
02476 | ||
dei |
City Area Code
CityAreaCode
|
781 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
996-5252 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.001 par value per share | ||
dei |
Trading Symbol
TradingSymbol
|
KALA | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
2693116 | |
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
56063000 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
70495000 | |
CY2023Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1839000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
7852000 | |
CY2022Q4 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
7595000 | |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
57902000 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
85942000 | |
CY2023Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
802000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
400000 | |
CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2102000 | |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
16000 | |
CY2023Q3 | kala |
Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
|
314000 | |
CY2022Q4 | kala |
Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
|
462000 | |
CY2023Q3 | us-gaap |
Assets
Assets
|
61120000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
86820000 | |
CY2023Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
787000 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2832000 | |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6260000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
8910000 | |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
4189000 | |
CY2023Q3 | us-gaap |
Deferred Income Current
DeferredIncomeCurrent
|
2930000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
324000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
13000 | |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
5000000 | |
CY2022Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
4146000 | |
CY2022Q4 | kala |
Deferred Purchase Consideration Current
DeferredPurchaseConsiderationCurrent
|
595000 | |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10301000 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
25685000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1880000 | |
CY2023Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
33878000 | |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
37937000 | |
CY2023Q3 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
3838000 | |
CY2022Q4 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
4224000 | |
CY2023Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
39596000 | |
CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
42161000 | |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
49897000 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
67846000 | |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2693116 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1706971 | |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
3000 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2000 | |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
632001000 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
606182000 | |
CY2023Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
1000 | |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-620782000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-587210000 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11223000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
18974000 | |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
61120000 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
86820000 | |
CY2022Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
420000 | |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
3892000 | ||
CY2022Q3 | kala |
Product Revenue Cost
ProductRevenueCost
|
11000 | |
kala |
Product Revenue Cost
ProductRevenueCost
|
2560000 | ||
CY2023Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4952000 | |
CY2022Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
9549000 | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
15944000 | ||
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
59204000 | ||
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5554000 | |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5391000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13868000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14330000 | ||
CY2022Q3 | kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
57000 | |
kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
230000 | ||
kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
-205000 | ||
CY2023Q3 | kala |
Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
|
1744000 | |
CY2022Q3 | kala |
Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
|
-95000 | |
kala |
Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
|
-462000 | ||
kala |
Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
|
952000 | ||
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
8762000 | |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
14989000 | |
us-gaap |
Operating Expenses
OperatingExpenses
|
30044000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
75347000 | ||
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8762000 | |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14569000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-30044000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-71455000 | ||
CY2023Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
708000 | |
CY2022Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
234000 | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2101000 | ||
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
310000 | ||
CY2023Q3 | us-gaap |
Interest Expense
InterestExpense
|
1459000 | |
CY2022Q3 | us-gaap |
Interest Expense
InterestExpense
|
1447000 | |
us-gaap |
Interest Expense
InterestExpense
|
4346000 | ||
us-gaap |
Interest Expense
InterestExpense
|
5689000 | ||
CY2023Q3 | kala |
Income From Grants
IncomeFromGrants
|
2970000 | |
kala |
Income From Grants
IncomeFromGrants
|
2970000 | ||
CY2022Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-2583000 | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-2583000 | ||
CY2022Q3 | us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
46995000 | |
us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
46995000 | ||
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2161000 | |
CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
443000 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4253000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
443000 | ||
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
58000 | |
CY2022Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
43642000 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3528000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
39476000 | ||
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8704000 | |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
29073000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-33572000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-31979000 | ||
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.41 | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
19.39 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-14.36 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-21.46 | ||
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-3.41 | |
CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
19.25 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-14.36 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-21.46 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2550210 | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1499001 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2337492 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1490159 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2550210 | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1510421 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2337492 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1490159 | ||
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8704000 | |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
29073000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-33572000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-31979000 | ||
CY2023Q3 | kala |
Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
|
-8000 | |
CY2022Q3 | kala |
Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
|
1000 | |
kala |
Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
|
1000 | ||
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-8000 | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1000 | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1000 | ||
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-8712000 | |
CY2022Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
29074000 | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-33571000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-31979000 | ||
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17492000 | |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
40000 | |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2403000 | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-8000 | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8704000 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11223000 | |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-31554000 | |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
138000 | |
CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1374000 | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
1000 | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
29073000 | |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-968000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
18974000 | |
kala |
Payments Of Stock Issuance Costs At Market Offering
PaymentsOfStockIssuanceCostsAtMarketOffering
|
446000 | ||
kala |
Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
|
17966000 | ||
us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
46000 | ||
us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
365000 | ||
kala |
Asset Acquisition Contingent Milestone Consideration Equity Interest Issued Or Issuable
AssetAcquisitionContingentMilestoneConsiderationEquityInterestIssuedOrIssuable
|
2354000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5089000 | ||
us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
1000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-33572000 | ||
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11223000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
16804000 | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3000 | ||
us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
298000 | ||
us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
7936000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5970000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-31979000 | ||
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-968000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-33572000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-31979000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
233000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
457000 | ||
kala |
Non Cash Operating Lease
NonCashOperatingLease
|
94000 | ||
kala |
Non Cash Operating Lease
NonCashOperatingLease
|
421000 | ||
us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
46995000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-2583000 | ||
kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
230000 | ||
kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
-205000 | ||
kala |
Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
|
-462000 | ||
kala |
Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
|
952000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
941000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
1130000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5089000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6048000 | ||
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
4322000 | ||
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-76000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-78000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-15143000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-5892000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
16928000 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-7544000 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1011000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
143000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2036000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
2433000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-319000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
4531000 | ||
kala |
Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
|
58000 | ||
kala |
Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
|
-335000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-20231000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-65173000 | ||
us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
62908000 | ||
kala |
Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
|
603000 | ||
kala |
Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
|
291000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
47000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
41000 | ||
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
9866000 | ||
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
4992000 | ||
us-gaap |
Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
10000000 | ||
us-gaap |
Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
5000000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-422000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
62666000 | ||
kala |
Payment Of Principal On Venture Debt Facility
PaymentOfPrincipalOnVentureDebtFacility
|
10000000 | ||
kala |
Payment Of Principal On Venture Debt Facility
PaymentOfPrincipalOnVentureDebtFacility
|
40000000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
17966000 | ||
kala |
Payment O Cash Portion Of Dosing Milestone
PaymentOCashPortionOfDosingMilestone
|
2041000 | ||
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
29000 | ||
us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
46000 | ||
us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
301000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5971000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-39728000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-14682000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-42235000 | ||
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
70745000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
94878000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
56063000 | |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
52643000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
56063000 | |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
52643000 | |
CY2022Q3 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
250000 | |
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
56063000 | |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
52393000 | |
kala |
Capital Expenditures Incurred But Not Yet Paid Accounts Payable
CapitalExpendituresIncurredButNotYetPaidAccountsPayable
|
16000 | ||
kala |
Issuance Of Common Stock To Satisfy Deferred Purchase Consideration In Additional Paid In Capital
IssuanceOfCommonStockToSatisfyDeferredPurchaseConsiderationInAdditionalPaidInCapital
|
365000 | ||
kala |
Asset Acquisition Contingent Milestone Consideration Equity Interest Issued Or Issuable
AssetAcquisitionContingentMilestoneConsiderationEquityInterestIssuedOrIssuable
|
2354000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
3477000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
4747000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
2180000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
424000 | ||
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
50 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8704000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-33572000 | ||
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
29073000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-31979000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-20231000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-65173000 | ||
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-620782000 | |
CY2022 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
31000000 | |
CY2022Q3 | kala |
Disposal Group Including Discontinued Operation Number Of Milestone Payments Per Calendar Year
DisposalGroupIncludingDiscontinuedOperationNumberOfMilestonePaymentsPerCalendarYear
|
1 | |
CY2022Q3 | kala |
Disposal Group Including Discontinued Operation Number Of Milestone Payments Per Calendar Year
DisposalGroupIncludingDiscontinuedOperationNumberOfMilestonePaymentsPerCalendarYear
|
1 | |
CY2022Q4 | kala |
Due From Alcon
DueFromAlcon
|
5394000 | |
CY2023Q3 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
0 | |
CY2022Q4 | us-gaap |
Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
|
7544000 | |
CY2022Q4 | us-gaap |
Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
|
51000 | |
CY2022Q4 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
7595000 | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
7935000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
365000 | ||
CY2023Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
0 | |
CY2022Q3 | kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
57000 | |
kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
230000 | ||
kala |
Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
|
-205000 | ||
kala |
Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
|
0 | ||
CY2023Q3 | kala |
Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
|
0 | |
CY2022 | kala |
Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
|
0 | |
us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
143000 | ||
CY2023Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
46000 | |
CY2023Q3 | kala |
Royalty On Net Sales As Percent
RoyaltyOnNetSalesAsPercent
|
0.001 | |
CY2023Q3 | kala |
Royalty On Net Sales Based On Of Funds Utilized By Company
RoyaltyOnNetSalesBasedOnOfFundsUtilizedByCompany
|
1000000 | |
CY2023Q3 | kala |
Term Of Royalty From Date Of First Commercial Sale Of Such Product Service Or Approved Drug
TermOfRoyaltyFromDateOfFirstCommercialSaleOfSuchProductServiceOrApprovedDrug
|
P10Y | |
CY2023Q3 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
918000 | |
CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
698000 | |
CY2023Q3 | us-gaap |
Nontrade Receivables Current
NontradeReceivablesCurrent
|
143000 | |
CY2022Q4 | us-gaap |
Nontrade Receivables Current
NontradeReceivablesCurrent
|
908000 | |
CY2023Q3 | us-gaap |
Unbilled Receivables Current
UnbilledReceivablesCurrent
|
117000 | |
CY2022Q4 | us-gaap |
Unbilled Receivables Current
UnbilledReceivablesCurrent
|
195000 | |
CY2023Q3 | kala |
Due From Alcon
DueFromAlcon
|
12000 | |
CY2022Q4 | kala |
Due From Alcon
DueFromAlcon
|
5394000 | |
CY2023Q3 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
649000 | |
CY2022Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
657000 | |
CY2023Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1839000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
7852000 | |
CY2022Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
114000 | |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
52000 | ||
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
740000 | ||
CY2023Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2783000 | |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3334000 | |
CY2023Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
487000 | |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
948000 | |
CY2023Q3 | kala |
Accrued Revenue Reserves
AccruedRevenueReserves
|
1659000 | |
CY2022Q4 | kala |
Accrued Revenue Reserves
AccruedRevenueReserves
|
807000 | |
CY2023Q3 | kala |
Development Costs Current
DevelopmentCostsCurrent
|
547000 | |
CY2022Q4 | kala |
Development Costs Current
DevelopmentCostsCurrent
|
446000 | |
CY2023Q3 | kala |
Accrued Contract Manufacturing
AccruedContractManufacturing
|
375000 | |
CY2022Q4 | kala |
Accrued Contract Manufacturing
AccruedContractManufacturing
|
453000 | |
CY2023Q3 | kala |
Accrued Commercialization Cost
AccruedCommercializationCost
|
153000 | |
CY2022Q4 | kala |
Accrued Commercialization Cost
AccruedCommercializationCost
|
271000 | |
CY2022Q4 | kala |
Due To Third Party
DueToThirdParty
|
2244000 | |
CY2023Q3 | kala |
Other Accrued Expenses Current
OtherAccruedExpensesCurrent
|
256000 | |
CY2022Q4 | kala |
Other Accrued Expenses Current
OtherAccruedExpensesCurrent
|
407000 | |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6260000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
8910000 | |
CY2023Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
149000 | |
CY2022Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
9000 | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
165000 | ||
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
404000 | ||
CY2023Q3 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
20000 | |
CY2022Q3 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
49000 | |
us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
132000 | ||
CY2023Q3 | us-gaap |
Lease Cost
LeaseCost
|
215000 | |
CY2022Q3 | us-gaap |
Lease Cost
LeaseCost
|
172000 | |
us-gaap |
Lease Cost
LeaseCost
|
349000 | ||
us-gaap |
Lease Cost
LeaseCost
|
1287000 | ||
CY2023Q3 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
48000 | |
CY2022Q3 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
338000 | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
61000 | ||
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1308000 | ||
CY2023Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y10M24D | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P0Y6M | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.104 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
143000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
581000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
601000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
622000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
644000 | |
CY2023Q3 | kala |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
440000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
827000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2204000 | |
CY2023Q3 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.1721 | |
CY2023Q3 | us-gaap |
Long Term Debt
LongTermDebt
|
33957000 | |
CY2022Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
43303000 | |
CY2023Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
602000 | |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
806000 | |
CY2023Q3 | kala |
Debt Instrument Exit Fees Of Total Principal Payments Value
DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue
|
523000 | |
CY2022Q4 | kala |
Debt Instrument Exit Fees Of Total Principal Payments Value
DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue
|
440000 | |
CY2023Q3 | kala |
Adjusted Long Term Debt
AdjustedLongTermDebt
|
33878000 | |
CY2022Q4 | kala |
Adjusted Long Term Debt
AdjustedLongTermDebt
|
42937000 | |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
5000000 | |
CY2023Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
33878000 | |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
37937000 | |
kala |
Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
|
4303 | ||
CY2022 | kala |
Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
|
4303 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
75000000 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
565974 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
75000000 | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
112597 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.084 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.231 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0355 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0443 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
12.82 | ||
CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2403000 | |
CY2022Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1327000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5089000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6048000 | ||
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8704000 | |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
29073000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-33572000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-31979000 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2550210 | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1499001 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2337492 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1490159 | ||
CY2022Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
11420 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2550210 | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1510421 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2337492 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1490159 | ||
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.41 | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
19.39 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-14.36 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-21.46 | ||
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-3.41 | |
CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
19.25 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-14.36 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-21.46 | ||
CY2023Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6623965 | |
CY2022Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
226050 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6350427 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
257865 | ||
CY2022Q4 | kala |
Tax Credit Carryforward Amount Annual Limitation
TaxCreditCarryforwardAmountAnnualLimitation
|
222000 | |
CY2023Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 | ||
CY2022 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 |